Butanoic acid, 3-methyl-2-[[[(phenylmethoxy)carbonyl]amino]methyl]-, (2R)-, 96%, 250mg

(2-Methylthiazol-5-yl)methanamine, 97%, 250mg

2-(4-Bromo-2-trifluoromethyl-benzylidene)-malononitrile, 95.0%, 1g

2,3-Dihydroisoquinolin-4(1H)-one hydrochloride, 95.0%, 250mg

[1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride>95.0%(T)5g

ácido ortofosfórico 75%, 75%, extrapuro, 2,5 l, envase de plástico.

Ethyl 2-(2-chloropyridin-3-yl)-2-oxoacetate, 95.0%, 250mg

5-Bromo-5-nitro-1,3-dioxane, 98.0%, 5g

N,N-DIETHYLSALICYLAMIDE, 97.0%, 25g

5-Bromo-2-((tetrahydro-2H-pyran-4-yl)oxy)pyridine, 95.0%, 1g

3-Amino-3-(2,5-dichlorophenyl)propanoic acid, 98%, 5g

Puntos de filtro MμltiGuard® 1-20 μl estériles, LowBinding, Caja, 960 Piezas

Methyl 3-hydroxy-5-trifluoromethylthiophene-2-carboxylate, 95+%, 5g